A directed share issue related to the reward payment of DNA's Share-Based Compensation Plan

DNA PLC STOCK EXCHANGE RELEASE 4 DECEMBER, 2017 at 11:00 am (EET)

The Board of Directors of DNA Plc has on 23 November 2017 decided on a directed share issue related to the reward payment of company's Share-Based Compensation Plan 2014.

In the share issue, a total of 703,080 treasury shares held by the company have been conveyed without consideration to the key employees participating in the plan in accordance with the terms and conditions of the plan. More detailed information about the terms and conditions of the plan is available in DNA's website: https://corporate.dna.fi/corporate-governance#palkitseminen. 

The decision on the directed share issue is based on the authorisation granted to the Board of Directors of DNA by the Annual General Meeting of Shareholders held on 22 March 2017.

The number of treasury shares after the directed share issue, on 4 December, 2017 is 264,817 shares.

More information about DNA's share-based compensation can be found from the Annual Report 2016: http://annualreport.dna.fi/pdf/DNA_annual_report_2016.pdf

Further enquiries:
Investor relations, Marja Mäkinen, +358 44 044 1262, [email protected]
DNA Corporate Communications, +358 44 044 8000, [email protected] 

DNA Plc is a Finnish telecommunications group providing high-quality voice, data and TV services for communication, entertainment and working. DNA is Finland's largest cable operator and the leading pay TV provider in both cable and terrestrial networks. For DNA, the key area for growth in corporate business is the new way of working, independent of time and place, facilitated by smart terminal devices, diverse communications services and rapid connections. In 2016, DNA recorded net sales of EUR 859 million and an operating profit of EUR 91 million. DNA has more than 3.8 million subscriptions in its fixed and mobile communications networks. The Group also includes DNA Store, Finland's largest retail chain selling mobile phones. DNA shares are listed on Nasdaq Helsinki Ltd. For further information, visit www.dna.fi or follow us on Twitter @DNA_fi, @DNA_Business and @DNA_Palvelu and Facebook.